A detailed history of Jpmorgan Chase & CO transactions in Psychemedics Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 11 shares of PMD stock, worth $25. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11
Previous 12 8.33%
Holding current value
$25
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$1.64 - $2.44 $1 - $2
-1 Reduced 8.33%
11 $0
Q1 2024

May 10, 2024

BUY
$2.92 - $3.79 $11 - $15
4 Added 50.0%
12 $0
Q4 2023

Feb 12, 2024

BUY
$2.06 - $3.69 $6 - $11
3 Added 60.0%
8 $0
Q3 2023

Nov 14, 2023

BUY
$3.66 - $5.05 $18 - $25
5 New
5 $0

Others Institutions Holding PMD

About PSYCHEMEDICS CORP


  • Ticker PMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 5,626,200
  • Market Cap $13.1M
  • Description
  • Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...
More about PMD
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.